Spyre Therapeutics Funding & Investors
San Francisco, CA
Spyre Therapeutics combines best-in-class antibody engineering, rational therapeutic combinations, and precision immunology approaches to maximize efficacy, safety, and convenience of treatments for inflammatory bowel disease.
spyre.comTotal Amount Raised: $360,000,000
Spyre Therapeutics Funding Rounds
Post Ipo Equity
$180,000,000
Post Ipo Equity Investors
Perceptive AdvisorsBoxer CapitalDeep Track CapitalAdage Capital ManagementFarallon Capital ManagementLogos CapitalAvidity PartnersRTW InvestmentsDarwin GlobalPost Ipo Equity
$180,000,000
Post Ipo Equity Investors
Affinity Asset AdvisorsGreat Point CapitalBoxer CapitalCommodore CapitalDeep Track CapitalWoodline PartnersAccess IndustriesCormorant Asset ManagementVenrock Healthcare Capital PartnersRTW InvestmentsPerceptive AdvisorsFairmount Funds ManagementBRAIDWELLPolar CapitalIPO
Unknown
Funding info provided by Diffbot.